Ashton Thomas Private Wealth
RMD icon

Ashton Thomas Private Wealth’s ResMed RMD Stock Holding History

Ashton Thomas Private Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$321K Buy
1,452
+302
+26% +$65.9K 0.01% 973
2026
Q2 		$224K Sell
1,150
-276
-19% -$57.2K ﹤0.01% 1105
2026
Q1 		$320K Buy
+1,426
New +$355K 0.01% 863
2024
Q3 		– Sell
-37
Closed -$7.08K – 1564
2024
Q2 		$7.08K Buy
+37
New +$7.51K ﹤0.01% 1438

Other funds holding RMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Ashton Thomas Private Wealth's RMD Position: Q3 2026 in Review

Ashton Thomas Private Wealth increased its ResMed (RMD) stake by 26% in Q3 2026, buying an estimated $65.9K and bringing the position to 1,452 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #973.

Ashton Thomas Private Wealth first reported a position in RMD in Q2 2024 and has held it in 4 quarters since. 480 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Ashton Thomas Private Wealth held 1,452 shares of ResMed worth $321K as of Q3 2026.
  • Ashton Thomas Private Wealth bought 302 ResMed shares in Q3 2026, an estimated $65.9K.
  • ResMed made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #973 holding.
  • Ashton Thomas Private Wealth first reported a position in ResMed in Q2 2024 and has held it in 4 quarters since.
  • 480 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.